Obesity refers to body mass index (BMI) greater than 30kg/m 2 . The present study aims to assess firstly, obesity as an independent risk factor for decreased activity of antioxidant enzymes in humans and secondly, its role in complicating glucose and lipid metabolism in type 2 diabetic subjects.
The subjects with healthy BMI had significantly higher (p<0.001) erythrocyte SOD (1443.45 ± 176.84 units/gHb) and GPX (95.1 ± 3.6 units/g Hb) than those with BMI above 40kg/m2 (986.0 ± 25.0 units/ gHb) and (80.8 ± 7.2 units/gHb). The values (in mg/dl) of cholesterol (C) 276.03 ± 4.62, triglycerides (TG) 186.6 ± 4.02, high density lipoprotein-C (HDL-C) 30.98 ± 0.92,very low density lipoprotein-C (VLDL-C) 37.3 ± 0.76 and low density lipoprotein-C (LDL-C) 207.75 ± 9.23 respectively were significantly higher (p<0.001) in subgroup (a) compared to group2 (231.0 ± 8.43, 160.0 ± 5.53, 33.94 ± 1.37, 31.69 ± 1.09, 165.29 ± 6.69). Plasma glucose both fasting and post prandial levels (in mg/dl) showed a highly significant pattern (p<0.001) in subgroup (a) (151.7 ± 21.8, 223.03 ± 5.09) compared to group 2(130.34 ± 3.59, 158.2 ± 8.9 ).
It is concluded from the results that obesity alone without the additional factors such as hypertension, diabetes mellitus, hyperlipidemia and smoking causes decreased activity of antioxidant enzymes and should receive the similar attention as obesity with complications. Also, with obesity insulin resistance worsens and the dyslipidemia in type 2 diabetics impairs further. The present study will estimate LDL-cholesterol by both Friedewald's calculation and homogenous assays and compare the results of Friedewald calculation with that of homogeneous assay.
191 Subjects of Lipid Profile were taken for the present study. All lipid profile cases were aged between 15 to 85, 74 were male and 117 were female. Serum Total Cholesterol, Triglyceride, HDL-direct, and LDL-direct were estimated by XL-600 Auto analyzer. HDL-indirect is measured by semi auto analyzer. LDLindirect was estimated by Friedewald Calculation.
In our study, we found a significant difference in direct homogeneous assay and Friedewald's estimation for LDL-c in all TG range when HDL-direct assay values were used in formula, but when HDL assay by precipitation method values were used, at low TG levels there was no statistically significant difference observed in LDL-c value between the two methods Assessing the results according to the different levels of Total cholesterol, the LDL-c estimate by the Friedewald formula when HDL measured by direct assay as well as precipitation method in the formula, was observed to have significant difference (p<0.001), as compared with the direct method.
More studies are needed to validate the direct assay in Indian population and explain the high values obtained as compared to Friedewald's estimation.
P4.3
Screening of Gestational Diabetes with Oral Gulcose Challenge Test. In the present study we find the prevalence of GDM (Gestational Diabetes Mellitus) in obstetric population and sensitivity of specificity of OGCT (oral glucose challenge test) in screening the population.
Universal versus Selective
This study was carried out on hundred pregnant women attending the OPD in SAIMS and BHRC hospital, Indore during the time period of March 2006 to February 2007. All subjects were screened for GDM by 50 gm, 1 hr OGCT. If the OGCT was positive the respective patient was subjected to 100 gms, 3 hrs OGTT ( Oral Glucose Tolerance Test). If OGTT is positive the patient was labelled as GDM case.
Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) Analyzing the data we found that 54% of study population had risk factor for GDM, 26.6% of screening positive patients had a positive OGTT. The overall prevalence of GDM was 5% in our population. In conclusion the prevalence of GDM in this part of our country is low and most of the patients of GDM had one or more risk factors. Our study supports the concept of universal screening for GDM as recommended by ADA position statement.
P4.4
Effect of Hypothyroidism on Lipid Profile The objective of the study is to asses the effect of hypothyroidism on lipid profile and Low Density lipoprotein (LDL) oxidation.
The sixty-five subjects aged between 30 -75 years were selected for study of hypothyroidism. They were divided into two groups, group I includes hypothyroidism subjects (n=40) and group II includes normal subjects (n=25) The study concluded that hypothyroidism induced dyslipdemia which may be risk factor for cardiac disorders.
P4.5
Status of Lipid per Oxidation, Glutathione, Ascorbic Acid, Vitamin E and Antioxidant Enzymes in Patients with Diabetic Nephropathy
Krishna Mohan Surapaneni
Department of Biochemistry, Mahavir Institute of Medical Sciences, Vikarabad, A.P.
Non Insulin Dependent Diabetes Mellitus is responsible for 60% cases of retinopathy in the population and is one of the common cause of blindness. The present study is to assess the alteration in the oxidant & antioxidant profile in patients with diabetic nephropathy. The changes in the erythrocyte lipid peroxidation products (MDA), levels of glutathione (GSH), ascorbic acid and plasma vitamin E (non enzymatic antioxidant parameters) and activities of antioxidant enzymessuperoxide dismutase (SOD), glutathione peroxi-Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) dase (GPX), catalase in erythrocytes and plasma glutathione -S -transferase (GST) were studied.
In the present study fifty-eight diabetics with out any complications, forty eight diabetics with proliferative and forty eight diabetics with non proliferative retinopathy were analyzed for the above said parameters. These parameters were also analyzed in forty-eight healthy subjects as controls. The venous blood samples obtained from these subjects were used for the estimation of GSH, ascorbic acid, SOD, GPX ,catalase, MDA in erythrocytes and vitamin E & GST in plasma. GSH was estimated by the method of buetler et al. Ascorbic acid levels were estimated by the method of teitz. Plasma vitamin E levels were estimated by the method of baker H et al. Erythrocyte MDA was determined as the measure of TBARS. SOD activity was determined in the hemolysate according to the method desribed by murklund and murklund. Catalase activity was measured in the hemolysate by the method of sinha. The activity of GPX was measured as described by paglia and valentine in erythrocytes and activity of GST was measured by using CDNB.
It was observed that the levels of MDA were elevated significantly ( p < 0.001) in patients compared to controls with the increase in severity and duration of the diabetes. The activities of antioxidant enzymes viz. SOD, GPX , GST were significantly increased as compared to controls with the progression of the disease. On the other hand, the levels of non-enzymatic antioxidants such as GSH, ascorbic acid, vitamin E and catalase activity were significantly decreased as compared to controls with the progression of the disease.
Free radical formation along with deficiency of antioxidants in diabetes mellitus increases over time to time and may play an important role in the development of diabetic retinopathy, which is an important complication of the disease.
P4.6
The Study of Lipid Profile and Liproprotein (a) Level in Nephrotic Syndrome Patients Jyoti Dwivedi, Purnima Dey Sarkar Mahatma Gandhi Memorial Medical College., Indore.
Lipid abnormalities in patients with Nephrotic Syndrome have long been recognized. To examine the influence of the lipid profile [total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDLs), low density lipoprotein cholesterol (LDLs), very low density lipoprotein cholesterol (VLDLs)] and lipoprotein a (Lp a) levels on Nephrotic Syndrome patients. Serum Lp (a) concentration is determines in order to investigate any abnormalities of lipoprotein metabolism in patients with Nephrotic Syndrome. Lp (a) level is known to be elevated in patients with ischeamic heart disease (IHD).
In the present study included 50 adult subjects consisting of 25 patients with Nephrotic Syndrome and 25 control subjects. Serum HDLs, LDLs, TG, TC were determined by using a commercially available kit methods (AGAPPE KIT). Lp (a) level were determined by turbidimetric method.
Patients with the Nephrotic Syndrome had elevated serum concentration of TC(459+159 vs. 183+28; Our result suggests altered lipid and lipoprotein metabolism in adult Nephrotic Syndrome patients. In the present study, significantly increased serum lipid profile and Lp (a) levels. It is concluded that hyperlipidaemia and hyperlipoproteinaemia may be risk factor for developing coronary heart disease in adult suffering from Nephrotic Syndrome P4.7
Age Related Changes in Lipid Profile
Beenu, G. Jaiswal
It is reported that prevalence of clinically significant vascular disease is four times greater in patients with dyslypidemia than in normal subjects . Therefore present study was designed to observe changes in anthropometry indices and lipid profile during ageing among the different aged subjects . As compared with young subjects, increased BMI was observed in group 2 & group 3 subjects (p<0.01). Except HDL cholesterol there were a general tendency to increase in lipid profile as age progressed. As BMI of all subjects from different age groups were found to be within normal limit range (20-24Kg/m 2 ) they can not be considered undernourished or overweight . As serum lipid profile were found to be elevated with age, an education programme is needed for the dietary modification & physical activity that may cause decrease in serum lipid profile level & reduce the risk of coronary artery diseases. Metabolic syndrome contributes to pathogenesis of Type-2 diabetes and CAD. Insulin Resistance is the key factor of metabolic syndrome implicated in development of Non Alcoholic Fatty Liver Disease (NAFLD).
In present study we have investigated the prevalence of NAFLD in metabolic syndrome and contribution of metabolic risk factors in causation of NAFLD in North Indian population.
The study was conducted on 995 nonalcoholic subjects (age 30-65 years). Metabolic Syndrome was assessed by using ATP III and ADA (2005) criteria. Anthropometric factors-Waist circumference and blood pressure were measured. Fasting serum samples were analyzed for Glucose, Triglyceride, Cholesterol and its fractions, Insulin, ALT, AST, GGT and free fatty acids (FFA). Insulin resistance and beta cell secretory capacity was estimated by Homeostasis Model and Insulin sensitivity by QUICKI Index. Creactive protein (hsCRP), fibrinogen and Plasminogen Activator Inhibitor-1 (PAI-1) were also estimated in serum. Liver ultrasonographic scanning was used for assessing fatty liver.
The prevalence of metabolic syndrome and NAFLD was 24% and 14.9% respectively in non-diabetic population and 27% of metabolic syndrome had NAFLD which was associated with hyperinsulinemia, insulin resistance, insulin insensitivity along with elevated levels of waist circumference, blood pressure, triglyceride, FFA, hsCRP, fibrinogen, PAI-1 and decreased HDL-Cholesterol. The prevalence of NAFLD increased with insulin resistance and clustering of metabolic risk factors. Insulin resistance, metabolic syndrome and hsCRP were found to be independent risk factors for NAFLD in multivariate analysis, Odds ratio being 1.52, 1.63, and 1.36 respectively at 95% CI, P<0.001.
Metabolic syndrome, Insulin resistance and Inflammation are important factors for fatty liver disease in apparently healthy non-alcoholic North Indian Population. Inhibition of HMG-CoA reductase not only inhibits biosynthesis of cholesterol but also inhibits biosynthesis of other end-products i.e. isoprenoids like Dolichol and CoQ10. Dolichol is involved in the biosynthesis of glycoprotein as a carrier of saccharide residues. CoQ10 has a crucial role in mitochondrial electron transport and lipophilic antioxidant activity. We therefore investigated the effect of atorvastatin treatment on total CoQ10 and Dolichol levels.
The study included 60 controls, 56 hypercholesterolemic patients (HL) and 62 diabetic hypercholesterolemic patients (DMHL). Patients were treated with atorvastatin (10mg/day) for 24 weeks. CoQ10 and Dolichol were analyzed by HPLC method.
We found that before treatment HL and DMHL groups have significantly high levels of CoQ10 as compared to control group (p<0.001), but DMHL group had a little lower levels of CoQ10 as compared to HL group. Dolichol content were significantly increased in HL and DMHL group compared to control (p<0.001) but HL and DMHL groups showed similar levels. We found that total cholesterol, triglyceride, low-density lipoprotein were decreased significantly by 45% (p<0.001), 32% (p<0.001) and 56% (p<0.001) respectively and high-density lipoprotein was increased by 7% (p<0.005). After treatment a significant decrease was observed in CoQ10 73% (p<0.001) while dolichol was decreased by 8% (p<0.005). CoQ10 and Dolichol did not show any correlation with lipids and with each other.
Though cholesterol, dolichol and CoQ10 share same biosynthetic pathway; inhibition of HMG-CoA reductase affect three end products in different manner. CoQ10 metabolism was severely affected then cholesterol but dolichols were least affected by inhibition of HMG-CoA reductase. Severe decrease in CoQ10 may be due to direct inhibition of biosynthesis as well as reduction in low-density lipoprotein which acts as CoQ10 carrier. The goal of this study was to ascertain the prevalence of Dyslipidemia among an urban young adult population in India.
The study was conducted for a priod of one year -from 1st January 2006 to 31st December 2006, and covered 1805 subjects with < 40 age group selected from a population of approximately 9000 urban dwellers who had attended annual general health examinations in P.D. Hinduja Hospital. Health status was determined by questionnaires and physical check ups and participants with complete fasting lipid profiles and blood glucose levels were evaluated. Total Cholesterol (TC), LDL -Cholesterol (LDL-C), HDL Cholesterol (HDL-C), Total Triglycerides (TGs), VLDL, Fasting Blood Sugar (FBS) and Postprandial Blood Suar (PBS) were measured. Dyslipidemia risk and impaired blood sugar levels were determined as per National Cholesterol Education Program (NCEP) -ATPIII guidelines and American Diabetes Association (ADA) respectively.
The prevalence of dyslipidemia was observed to be higher in males than in females. Among participants who had a TC concentration > 200mg/dl, 3.7% were males and 23.3% were females. HDL-C was abnormally low in 35.5% males and 66.2% in females. The increase of prevalence of hypercholesterolemia and hypertriglyceridemia was more prominent in (31-40) age group than in < 30 age group.
The low percentage of adults with controlled lipid concentrations suggests the need for a renewed commitment to the prevention and control of Dyslipidemia and impaired blood sugar levels. Awareness programs are needed to optimize management of Dyslipidemia.
